Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say
Published
Merck & Co. Inc. on Tuesday filed a lawsuit against the federal government, alleging that the Medicare drug price negotiation program established last year as part of the Inflation Reduction Act is “tantamount to extortion.” The program does not involve genuine negotiation, Merck alleged in the…
#merckcoinc #medicare #merck #rahway #newjersey #xavierbecerra #robinfeldman #marketwatch #supremecourt #healthforum